| For: | Harris RE, Casto BC, Harris ZM. Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J Clin Oncol 2014; 5(4): 677-692 [PMID: 25302170 DOI: 10.5306/wjco.v5.i4.677] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i4/677.htm |
| Number | Citing Articles |
| 1 |
Rania Harati, Aloïse Mabondzo, Abdelaziz Tlili, Ghalia Khoder, Mona Mahfood, Rifat Hamoudi. Combinatorial targeting of microRNA-26b and microRNA-101 exerts a synergistic inhibition on cyclooxygenase-2 in brain metastatic triple-negative breast cancer cells. Breast Cancer Research and Treatment 2021; 187(3) doi: 10.1007/s10549-021-06255-y
|
| 2 |
Michael Thoene, Kamila Zglejc-Waszak, Marcin Jozwik, Joanna Wojtkiewicz. Bisphenol A Promotes the Progression of Hormone-Sensitive Breast Cancers Through Several Inflammatory Pathways. Cancers 2025; 17(14) doi: 10.3390/cancers17142373
|
| 3 |
Reece G. Kenny, Celine J. Marmion. Metal-based Anticancer Agents. 2019; doi: 10.1039/9781788016452-00001
|
| 4 |
Swetlana Gautam, Atul K. Rawat, Shreesh R. Sammi, Subhadeep Roy, Manjari Singh, Uma Devi, Rajnish K. Yadav, Lakhveer Singh, Jitendra K. Rawat, Mohd N. Ansari, Abdulaziz S. Saeedan, Dinesh Kumar, Rakesh Pandey, Gaurav Kaithwas. DuCLOX-2/5 Inhibition Attenuates Inflammatory Response and Induces Mitochondrial Apoptosis for Mammary Gland Chemoprevention. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00314
|
| 5 |
|
| 6 |
Edna Zhi Pei Chai, Kodappully Sivaraman Siveen, Muthu K. Shanmugam, Frank Arfuso, Gautam Sethi. Analysis of the intricate relationship between chronic inflammation and cancer. Biochemical Journal 2015; 468(1) doi: 10.1042/BJ20141337
|
| 7 |
Trinidad Dierssen-Sotos, Inés Gómez-Acebo, María de Pedro, Beatriz Pérez-Gómez, Sonia Servitja, Víctor Moreno, Pilar Amiano, Tania Fernandez-Villa, Aurelio Barricarte, Adonina Tardon, Marian Diaz-Santos, Rosana Peiro-Perez, Rafael Marcos-Gragera, Virginia Lope, Esther Gracia-Lavedan, M. Henar Alonso, Maria Jesus Michelena-Echeveste, Andrés Garcia-Palomo, Marcela Guevara, Gemma Castaño-Vinyals, Nuria Aragonés, Manolis Kogevinas, Marina Pollán, Javier Llorca. Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2692-4
|
| 8 |
Sebanti Ganguly, Itika Arora, Trygve O. Tollefsbol. Impact of Stilbenes as Epigenetic Modulators of Breast Cancer Risk and Associated Biomarkers. International Journal of Molecular Sciences 2021; 22(18) doi: 10.3390/ijms221810033
|
| 9 |
Hiba Mahmoud, Mohammed Hamzah, Tabarak Talab, Russl Mhana. Cyclooxygenase‑2 concentration and prostaglandin E2 levels in sera and urine of women with breast cancer. World Academy of Sciences Journal 2026; 8(3) doi: 10.3892/wasj.2026.456
|
| 10 |
Swati Singh, Manika Awasthi, Veda P. Pandey, Upendra N. Dwivedi. Plant derived anti-cancerous secondary metabolites as multipronged inhibitor of COX, Topo, and aromatase: molecular modeling and dynamics simulation analyses. Journal of Biomolecular Structure and Dynamics 2017; 35(14) doi: 10.1080/07391102.2016.1241720
|
| 11 |
Yulin Peng, Yan Wang, Ning Tang, Dongdong Sun, Yulong Lan, Zhenlong Yu, Xinyu Zhao, Lei Feng, Baojing Zhang, Lingling Jin, Fabiao Yu, Xiaochi Ma, Chuanzhu Lv. Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0926-9
|
| 12 |
Seeya Awadhut Munj, Tasnimul Alam Taz, Suzan Arslanturk, Elisabeth I. Heath. Biomarker-driven drug repurposing on biologically similar cancers with DNA-repair deficiencies. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1015531
|
| 13 |
Anna Boss, Karen Bishop, Gareth Marlow, Matthew Barnett, Lynnette Ferguson. Evidence to Support the Anti-Cancer Effect of Olive Leaf Extract and Future Directions. Nutrients 2016; 8(8) doi: 10.3390/nu8080513
|
| 14 |
Yan Chen, Linming Li, Zhifang Liu, Meifeng Liu, Qingpeng Wang. A series of ligustrazine platinum(iv) complexes with potent anti-proliferative and anti-metastatic properties that exert chemotherapeutic and immunotherapeutic effects. Dalton Transactions 2023; 52(37) doi: 10.1039/D3DT02358C
|
| 15 |
Shuhang Gao, Yan Sun, Xue Liu, Dandan Zhang, Xuesong Yang. EpCAM and COX-2 expression are positively correlated in human breast cancer. Molecular Medicine Reports 2017; 15(6) doi: 10.3892/mmr.2017.6447
|
| 16 |
Zeynep Sude YALCIN, Mehmet Abdullah ALAGOZ, Oztekin ALGUL. FROM SINGLE TO DUAL TARGETING: RECENT ADVANCES IN EGFR-BASED DUAL INHIBITORS FOR CANCER THERAPY. European Journal of Medicinal Chemistry 2026; doi: 10.1016/j.ejmech.2026.119400
|
| 17 |
Yong‑Xia Wang, Zhe‑Ying Zhang, Jian‑Qiang Wang, Xin‑Lai Qian, Jing Cui. HPV16 E7 increases COX‑2 expression and promotes the proliferation of breast cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.8624
|
| 18 |
Hend Gamal, Walid Tawfik, Hassan IH El-Sayyad, Ahmed N. Emam, Heba Mohamed Fahmy, Heba A. El-Ghaweet. A new vision of photothermal therapy assisted with gold nanorods for the treatment of mammary cancers in adult female rats. Nanoscale Advances 2024; 6(1) doi: 10.1039/D3NA00595J
|
| 19 |
Theodore R. Witte, W. Elaine Hardman. The Effects of Omega‐3 Polyunsaturated Fatty Acid Consumption on Mammary Carcinogenesis. Lipids 2015; 50(5) doi: 10.1007/s11745-015-4011-2
|
| 20 |
Khaled Greish, Hayley Nehoff, Fatemah Bahman, Tara Pritchard, Sebastien Taurin. Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor. Journal of Drug Targeting 2019; 27(8) doi: 10.1080/1061186X.2019.1566341
|
| 21 |
Randall E. Harris, Judith A. Schwartzbaum. Celecoxib may be a viable treatment option for breast cancer patients not treated with chemotherapy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.958308
|
| 22 |
Pei Xin, Lei Wang, Xianyang Chen, Huazhi Li, Nan Jiang. Mediating factors between autoimmune thyroiditis and breast cancer: a bidirectional Mendelian randomization study. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03206-7
|
| 23 |
Gertraud Maskarinec, Dan Ju, Yurii B. Shvetsov, David Horio, Owen Chan, Lenora W.M. Loo, Brenda Y. Hernandez. Breast tumor tissue inflammation but not lobular involution is associated with survival among breast cancer patients in the Multiethnic Cohort. Cancer Epidemiology 2020; 65 doi: 10.1016/j.canep.2020.101685
|
| 24 |
David Hernán Martínez-Puente, Rodolfo Garza-Morales, José Juan Pérez-Trujillo, Federico Bernabé-Acosta, Arnulfo Villanueva-Olivo, Aracely García-García, Laura Mireya Zavala-Flores, Humberto Rodríguez-Rocha, Jesús Valdés, Odila Saucedo-Cárdenas, Roberto Montes de Oca-Luna, María de Jesús Loera-Arias. Enhanced antitumor activity induced by a DNA vaccine encoding E7 antigen fused to an ERAD-targeting sequence. Journal of Drug Targeting 2023; 31(1) doi: 10.1080/1061186X.2022.2107651
|
| 25 |
Elizabeth Divina, Linda Erlina, Khaerunissa Anbar Istiadi, Elfa Siska Yasa Putri, Fadilah Fadilah. QSAR and Anticancer effect of Alkyl salicylate on Breast cancer T47D Cells Lines. Research Journal of Pharmacy and Technology 2022; doi: 10.52711/0974-360X.2022.00773
|
| 26 |
Mandeep Kaur, Hafiz Muzzammel Rehman, Gurmeet Kaur, Amandeep Kaur, Manisha Bansal. Switching of newly synthesized linker-based derivatives of non-steroidal anti-inflammatory drugs toward anti-inflammatory and anticancer activity. Bioorganic Chemistry 2023; 133 doi: 10.1016/j.bioorg.2023.106406
|
| 27 |
Monika Berbecka, Alicja Forma, Jacek Baj, Marzena Furtak-Niczyporuk, Ryszard Maciejewski, Robert Sitarz. A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy. Journal of Clinical Medicine 2021; 10(19) doi: 10.3390/jcm10194443
|
| 28 |
Harshit Shah, Lizhi Pang, Steven Qian, Venkatachalem Sathish. Iminodibenzyl induced redirected COX-2 activity inhibits breast cancer progression. npj Breast Cancer 2021; 7(1) doi: 10.1038/s41523-021-00330-9
|
| 29 |
Xi Zhang, Nadia Harbeck, Udo Jeschke, Sophie Doisneau-Sixou. Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer. Journal of Cancer Research and Clinical Oncology 2017; 143(7) doi: 10.1007/s00432-016-2325-y
|
| 30 |
Bocheng Wu, Quaovi H. Sodji, Adegboyega K. Oyelere. Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges. Cancers 2022; 14(3) doi: 10.3390/cancers14030552
|
| 31 |
Jéssica Alessandra-Perini, Jamila Alessandra Perini, Karina Cristina Rodrigues-Baptista, Roberto Soares de Moura, Antonio Palumbo Junior, Thiago Alves dos Santos, Pergentino José Cunha Souza, Luiz Eurico Nasciutti, Daniel Escorsim Machado. Euterpe oleracea extract inhibits tumorigenesis effect of the chemical carcinogen DMBA in breast experimental cancer. BMC Complementary and Alternative Medicine 2018; 18(1) doi: 10.1186/s12906-018-2183-z
|
| 32 |
Shakti Ranjan Satapathy, Anita Sjölander. Nuclear PD-L1 regulates YAP-driven transcription via the PGE2-EP4-YAP-importin α3 axis in solid tumors. Cell Reports 2026; 45(2) doi: 10.1016/j.celrep.2026.116963
|
| 33 |
Chiara Benedetto, Francesca Salvagno, Emilie Marion Canuto, Gianluca Gennarelli. Obesity and female malignancies. Best Practice & Research Clinical Obstetrics & Gynaecology 2015; 29(4) doi: 10.1016/j.bpobgyn.2015.01.003
|
| 34 |
Diefeng Ren, Junjun Xiang, Xike Gao. Design, Synthesis, and Anti-inflammatory/Antioxidant Activities of Guaiazulene Dimers Bridged by Triethylene Glycol. Acta Chimica Sinica 2025; 83(10) doi: 10.6023/A25060209
|
| 35 |
Birgit M. Dietz, Atieh Hajirahimkhan, Tareisha L. Dunlap, Judy L. Bolton. Botanicals and Their Bioactive Phytochemicals for Women’s Health. Pharmacological Reviews 2016; 68(4) doi: 10.1124/pr.115.010843
|
| 36 |
Ghada H. Elsayed, Mariam G. Rizk, Asmaa M. Fahim, Nelly H. Mahmoud. Investigation of anticancer and anti-inflammatory efficacies of novel metal complexes: Spectroscopic and thermal characterization, computational investigation, and docking simulation. Inorganic Chemistry Communications 2025; 182 doi: 10.1016/j.inoche.2025.115427
|
| 37 |
Felipe Aguiar Pupo Seabra Malta, Debora Estadella, Daniela Caetano Gonçalves. The role of omega 3 fatty acids in suppressing muscle protein catabolism: A possible therapeutic strategy to reverse cancer cachexia?. Journal of Functional Foods 2019; 54 doi: 10.1016/j.jff.2018.12.033
|
| 38 |
Gilead Ebiegberi Forcados, Abdullahi Balarabe Sallau, Aliyu Muhammad, Ochuko Lucky Erukainure, Dorcas Bolanle James. Vitex doniana Leaves Extract Ameliorates Alterations Associated with 7, 12-Dimethyl Benz[a]Anthracene-Induced Mammary Damage in Female Wistar Rats. Nutrition and Cancer 2021; 73(1) doi: 10.1080/01635581.2020.1743866
|
| 39 |
Ruyuf Alfurayhi, Lei Huang, Kirsten Brandt. Pathways Affected by Falcarinol-Type Polyacetylenes and Implications for Their Anti-Inflammatory Function and Potential in Cancer Chemoprevention. Foods 2023; 12(6) doi: 10.3390/foods12061192
|
| 40 |
Nitin Shivappa, Sven Sandin, Marie Löf, James R Hébert, Hans-Olov Adami, Elisabete Weiderpass. Prospective study of dietary inflammatory index and risk of breast cancer in Swedish women. British Journal of Cancer 2015; 113(7) doi: 10.1038/bjc.2015.304
|
| 41 |
Sevil Şenkardeş, M. İhsan Han, Necla Kulabaş, Mürüvvet Abbak, Özge Çevik, İlkay Küçükgüzel, Ş. Güniz Küçükgüzel. Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors. Molecular Diversity 2020; 24(3) doi: 10.1007/s11030-019-09974-z
|
| 42 |
Ayse Tarbin Jannuzzi, Ayse Mine Yilmaz Goler, Deepak Shilkar, Subodh Mondal, Vinay N. Basavanakatti, Hatice Yıldırım, Mahmut Yıldız, Hülya Çelik Onar, Nilüfer Bayrak, Venkatesan Jayaprakash, Amaç Fatih TuYuN. Cytotoxic activity of quinolinequinones in cancer: In vitro studies, molecular docking, and ADME/PK profiling. Chemical Biology & Drug Design 2023; 102(5) doi: 10.1111/cbdd.14314
|
| 43 |
Daniely Regina Freitas-Alves, Hayra de Andrade Vieira-Monteiro, Diogo Nascimento Piranda, Marcelo Sobral-Leite, Taiana Sousa Lopes da Silva, Anke Bergmann, Samuel Santos Valença, Jamila Alessandra Perini, Rosane Vianna-Jorge. PTGS2 polymorphism rs689466 favors breast cancer recurrence in obese patients. Endocrine-Related Cancer 2018; 25(3) doi: 10.1530/ERC-17-0374
|
| 44 |
Nada Oršolić, Martina Kunštić, Marina Kukolj, Dyana Odeh, Daniela Ančić. Natural Phenolic Acid, Product of the Honey Bee, for the Control of Oxidative Stress, Peritoneal Angiogenesis, and Tumor Growth in Mice. Molecules 2020; 25(23) doi: 10.3390/molecules25235583
|
| 45 |
Nireshini Reddy, Catherine H. Kaschula, Nokwanda P. Makunga, Willem Jacobus Perold, Sanjeev Rambharose, Anna‐Mart Engelbrecht. Dodonaea viscosa in Breast Cancer: Phytochemistry, Anticancer Mechanisms, and Emerging Immunotherapeutic and Translational Perspectives. Cancer Medicine 2026; 15(10) doi: 10.1002/cam4.72240
|
| 46 |
Animesh Mandal, Deepak Bhatia, Anupam Bishayee. Anti-Inflammatory Mechanism Involved in Pomegranate-Mediated Prevention of Breast Cancer: the Role of NF-κB and Nrf2 Signaling Pathways. Nutrients 2017; 9(5) doi: 10.3390/nu9050436
|
| 47 |
Fernán Gómez-Valenzuela, Enrico Escobar, Ricardo Pérez-Tomás, Viviana P. Montecinos. The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.686792
|
| 48 |
Wei Xiong, Wen-Hui Li, Yong-Xin Jiang, Shan Liu, Yi-Qin Ai, Rong Liu, Li Chang, Ming Zhang, Xiao-Li Wang, Han Bai, Hong Wang, Rui Zheng, Jing Tan. Parecoxib: an Enhancer of Radiation Therapy for Colorectal Cancer. Asian Pacific Journal of Cancer Prevention 2015; 16(2) doi: 10.7314/APJCP.2015.16.2.627
|
| 49 |
Swetlana Gautam, Subhadeep Roy, Mohd Nazam Ansari, Abdulaziz S. Saeedan, Shubhini A. Saraf, Gaurav Kaithwas. DuCLOX-2/5 inhibition: a promising target for cancer chemoprevention. Breast Cancer 2017; 24(2) doi: 10.1007/s12282-016-0723-2
|
| 50 |
Kate R. Kuhlman, Sarah R. Horn, Jessica J. Chiang, Julienne E. Bower. Early life adversity exposure and circulating markers of inflammation in children and adolescents: A systematic review and meta-analysis. Brain, Behavior, and Immunity 2020; 86 doi: 10.1016/j.bbi.2019.04.028
|
| 51 |
Racha Karaky, Joumana Al-Akhdar, Fatima Saab, Batoul Rostom, Wassim Shebaby, Mohamed Mroueh, Mona Diab-Assaf, Issam Kassab, Maité Sylla-Iyarreta Veitia. Anticancer effect of new cyclocoumarol derivatives. European Journal of Medicinal Chemistry Reports 2024; 12 doi: 10.1016/j.ejmcr.2024.100220
|
| 52 |
Mohammad Fahad Ullah, Showket H. Bhat, Muhammad Tariq, Faisel M. Abuduhier. Biocatalysis. 2019; doi: 10.1007/978-3-030-25023-2_11
|
| 53 |
Md Sohel, Md. Nurul Islam, Md. Arju Hossain, Tayeba Sultana, Amit Dutta, Md. Sohanur Rahman, Suraiya Aktar, Khairul Islam, Abdullah Al Mamun, Pranshu Sahgal. Pharmacological Properties to Pharmacological Insight of Sesamin in Breast Cancer Treatment: A Literature-Based Review Study. International Journal of Breast Cancer 2022; 2022 doi: 10.1155/2022/2599689
|
| 54 |
Yalin Zhu, Yi Gong, Yifei Wang, Zhengyu Jiang, Ying Yao, Xiaoyong Miao, Shuoer Wang, Yan Zhang, Jianping Cao. Flurbiprofen axetil is involved in basal‐like breast cancer metastasis via suppressing the MEK/ERK signaling pathway. Cell Biology International 2025; 49(1) doi: 10.1002/cbin.12251
|
| 55 |
J. Ni, D. Yang, L. Song, C. Li. Protective effects of paeoniflorin on alveolar bone resorption and soft‐tissue breakdown in experimental periodontitis. Journal of Periodontal Research 2016; 51(2) doi: 10.1111/jre.12305
|
| 56 |
Eliza Vazquez, Yulia Lipovka, Alejandro Cervantes-Arias, Adriana Garibay-Escobar, Michelle M. Haby, Felisbina Luisa Queiroga, Carlos Velazquez. Canine Mammary Cancer: State of the Art and Future Perspectives. Animals 2023; 13(19) doi: 10.3390/ani13193147
|
| 57 |
Randall Harris, Joanne Beebe, Judith Schwartzbaum. Chemoprevention of breast cancer by cyclooxygenase and lipoxygenase inhibitors. World Academy of Sciences Journal 2020; doi: 10.3892/wasj.2020.34
|
| 58 |
Javier Amézaga, Gurutze Ugartemendia, Aitziber Larraioz, Nerea Bretaña, Aizpea Iruretagoyena, Joana Camba, Ander Urruticoechea, Carla Ferreri, Itziar Tueros. Altered Levels of Desaturation and ω-6 Fatty Acids in Breast Cancer Patients’ Red Blood Cell Membranes. Metabolites 2020; 10(11) doi: 10.3390/metabo10110469
|
| 59 |
Camilla Paulla de Souza, Beatriz Alves, Jaques Waisberg, Fernando Fonseca, Alipio de Oliveira Carmo, Flavia Gehrke. Detection of COX-2 in liquid biopsy in patients with breast cancer. Journal of Clinical Pathology 2020; 73(12) doi: 10.1136/jclinpath-2020-206576
|
| 60 |
Daniil Spector, Olga Krasnovskaya, Kirill Pavlov, Alexander Erofeev, Peter Gorelkin, Elena Beloglazkina, Alexander Majouga. Pt(IV) Prodrugs with NSAIDs as Axial Ligands. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22083817
|
| 61 |
Enrico Escobar, Cristian Peñafiel, Fernán Gómez‐Valenzuela, Eduardo Chimenos‐Küstner, Ricardo Pérez‐Tomás. Cyclooxygenase‐2 protein expression modulates cell proliferation and apoptosis in solid ameloblastoma and odontogenic keratocyst. An immunohistochemical study. Journal of Oral Pathology & Medicine 2021; 50(9) doi: 10.1111/jop.13237
|
| 62 |
Yogita Chhichholiya, Prabhat Suman, Sandeep Singh, Anjana Munshi. The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies. Medical Oncology 2021; 38(8) doi: 10.1007/s12032-021-01547-1
|
| 63 |
Animesh Mandal, Anupam Bishayee. Trianthema portulacastrum Linn. Displays Anti-Inflammatory Responses during Chemically Induced Rat Mammary Tumorigenesis through Simultaneous and Differential Regulation of NF-κB and Nrf2 Signaling Pathways. International Journal of Molecular Sciences 2015; 16(2) doi: 10.3390/ijms16022426
|
| 64 |
Nicoletta Del Buono, Flavia Esposito, Fabio Fumarola, Angelina Boccarelli, Mauro Coluccia. Machine Learning, Optimization, and Big Data. Lecture Notes in Computer Science 2016; 10122 doi: 10.1007/978-3-319-51469-7_24
|
| 65 |
Garhett L. Wyatt, Lyndsey S. Crump, Chloe M. Young, Veronica M. Wessells, Cole M. McQueen, Steven W. Wall, Tanya L. Gustafson, Yang-Yi Fan, Robert S. Chapkin, Weston W. Porter, Traci R. Lyons. Cross-talk between SIM2s and NFκB regulates cyclooxygenase 2 expression in breast cancer. Breast Cancer Research 2019; 21(1) doi: 10.1186/s13058-019-1224-y
|
| 66 |
Nataly Tarasenko, Harel Josef Wilner, Abraham Nudelman, Gania Kessler-Icekson, Ada Rephaeli. Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer. Pharmaceuticals 2021; 14(12) doi: 10.3390/ph14121244
|
| 67 |
Na Li, Qian Wang, Ting Zhu, Longwei Qiao, Fei Zhang, Rui Mi, Bo Wang, Lin Chen, Junxia Gu, Yaojuan Lu, Qiping Zheng. In vitro functional characterization of prostaglandin-endoperoxide synthase 2 during chondrocyte hypertrophic differentiation. Oncotarget 2016; 7(24) doi: 10.18632/oncotarget.8889
|
| 68 |
Louise Benoit, Florence Jornod, Elias Zgheib, Celine Tomkiewicz, Meriem Koual, Thibaut Coustillet, Robert Barouki, Karine Audouze, Mathieu Vinken, Xavier Coumoul. Adverse outcome pathway from activation of the AhR to breast cancer-related death. Environment International 2022; 165 doi: 10.1016/j.envint.2022.107323
|
| 69 |
Oana Zanoaga, Ancuta Jurj, Lajos Raduly, Roxana Cojocneanu‑Petric, Enrique Fuentes‑Mattei, Oscar Wu, Cornelia Braicu, Claudia Gherman, Ioana Berindan‑Neagoe. Implications of dietary ω‑3 and ω‑6 polyunsaturated fatty acids in breast cancer (Review). Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5515
|
| 70 |
Lars Porskjær Christensen. Bioactive C17 and C18 Acetylenic Oxylipins from Terrestrial Plants as Potential Lead Compounds for Anticancer Drug Development. Molecules 2020; 25(11) doi: 10.3390/molecules25112568
|
| 71 |
Oktay Ajikanari, Elham Miaadi, Mohaddeseh Hedayat, Reza Jafari, Rahim Asghari, Naime Majidi Zolbanin. Antitumor activity of celecoxib with docetaxel on human triple-negative breast cancer cells. Gene Reports 2025; 38 doi: 10.1016/j.genrep.2025.102141
|
| 72 |
Jesus Pacheco-Torres, Marie-France Penet, Yelena Mironchik, Balaji Krishnamachary, Zaver M. Bhujwalla. The PD-L1 metabolic interactome intersects with choline metabolism and inflammation. Cancer & Metabolism 2021; 9(1) doi: 10.1186/s40170-021-00245-w
|
| 73 |
Elizabeth Samuels, Jaclyn Parks, Jessica Chu, Treena McDonald, John Spinelli, Rachel A. Murphy, Parveen Bhatti. Metabolites Associated with Polygenic Risk of Breast Cancer. Metabolites 2024; 14(6) doi: 10.3390/metabo14060295
|
| 74 |
A. S. Komorowski, R. C. Pezo. Untapped “-omics”: the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment. Breast Cancer Research and Treatment 2020; 179(2) doi: 10.1007/s10549-019-05472-w
|
| 75 |
Mandeep Kaur, Hafiz Muzzammel Rehman, Yurong Wu, Gurmeet Kaur, Hafiz Muhammad Hammad, Yusuf Siraj Usmani, Amandeep Kaur, Manisha Bansal. Comprehensive analysis and outcomes of hybridization of physiologically active heterocycles targeting epidermal growth factor receptor (EGFR). Computers in Biology and Medicine 2025; 184 doi: 10.1016/j.compbiomed.2024.109347
|
| 76 |
Honor J. Hugo, C. Saunders, R. G. Ramsay, E. W. Thompson. New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis. Journal of Mammary Gland Biology and Neoplasia 2015; 20(3-4) doi: 10.1007/s10911-015-9333-4
|
| 77 |
Naing Naing Mon, Takeshi Senga, Satoko Ito. Interleukin-1β activates focal adhesion kinase and Src to induce matrix metalloproteinase-9 production and invasion of MCF-7 breast cancer cells. Oncology Letters 2017; 13(2) doi: 10.3892/ol.2016.5521
|
| 78 |
Ellen Cristina Rivas Leonel, Thalles Fernando Rocha Ruiz, Carolina Marques Bedolo, Silvana Gisele Pegorin Campos, Sebastião Roberto Taboga. Inflammatory repercussions in female steroid responsive glands after perinatal exposure to bisphenol A and 17‐β estradiol. Cell Biology International 2021; 45(11) doi: 10.1002/cbin.11665
|
| 79 |
Guillaume Jaume, Anurag Vaidya, Richard J. Chen, Drew F.K. Williamson, Paul Pu Liang, Faisal Mahmood. Modeling Dense Multimodal Interactions Between Biological Pathways and Histology for Survival Prediction. 2024 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) 2024; doi: 10.1109/CVPR52733.2024.01100
|
| 80 |
WEIYI SUN, GANG CHEN. Impact and mechanism of non-steroidal anti-inflammatory drugs combined with chemotherapeutic drugs on human lung cancer-nude mouse transplanted tumors. Oncology Letters 2016; 11(6) doi: 10.3892/ol.2016.4493
|
| 81 |
Zhi-Peng Feng, Hong-Yi Xin, Ze-Wei Zhang, Chen-Guang Liu, Zheng Yang, Hua You, Hong-Wu Xin. Gut microbiota homeostasis restoration may become a novel therapy for breast cancer. Investigational New Drugs 2021; 39(3) doi: 10.1007/s10637-021-01063-z
|
| 82 |
Chun-Xiong Zhao, Chun-Li Luo, Xiao-Hou Wu. Hypoxia promotes 786-O cells invasiveness and resistance to sorafenib via HIF-2α/COX-2. Medical Oncology 2015; 32(1) doi: 10.1007/s12032-014-0419-4
|
| 83 |
Melissa A. Johnson, Siva Karthik Varanasi, Kailash Chandra Mangalhara, Kathryn Lande, Gladys R. Rojas, Pau B. Esparza-Moltó, Mack B. Reynolds, Neva Olliffe, Karl Wessendorf-Rodriguez, Sagnika Ghosh, Dan Chen, Alexandra G. Moyzis, Matthew P. Donnelly, Rebecca Chinn, Ziyan Xu, Kym J. Grae, Victoria Tripple, Michael A. LaPorta, Christian M. Metallo, Diana C. Hargreaves, Susan M. Kaech, Gerald S. Shadel. Chronic type II interferon promotes tumor growth through mitochondrial RNA–induced type I interferon and prostaglandin synthesis. Science 2026; 393(6816) doi: 10.1126/science.aec0002
|
| 84 |
Eman F. Abdelhaleem, Asmaa E. Kassab, Hala B. El‐Nassan, Omneya M. Khalil. Design, synthesis, and biological evaluation of new celecoxib analogs as apoptosis inducers and cyclooxygenase‐2 inhibitors. Archiv der Pharmazie 2022; 355(11) doi: 10.1002/ardp.202200190
|
| 85 |
Shoib Sarwar Siddiqui, Rawad Hodeify, Shimy Mathew, Seba Alsawaf, Anood Alghfeli, Rachel Matar, Maxime Merheb, John Marton, Hussain AbdulKarim Al Zouabi, Dhiviya Prabaa Muthuirulandi Sethuvel, Naveen Kumar Devanga Ragupathi, Cijo George Vazhappilly. Differential dose–response effect of cyclosporine A in regulating apoptosis and autophagy markers in MCF-7 cells. Inflammopharmacology 2023; 31(4) doi: 10.1007/s10787-023-01247-4
|
| 86 |
Céline Gérard, Kristy A. Brown. Obesity and breast cancer – Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue. Molecular and Cellular Endocrinology 2018; 466 doi: 10.1016/j.mce.2017.09.014
|
| 87 |
Chenyu Pi, Ping Jing, Bingyu Li, Yan Feng, Lijun Xu, Kun Xie, Tao Huang, Xiaoqing Xu, Hua Gu, Jianmin Fang. Reversing PD-1 Resistance in B16F10 Cells and Recovering Tumour Immunity Using a COX2 Inhibitor. Cancers 2022; 14(17) doi: 10.3390/cancers14174134
|
| 88 |
Kejia Hu, Maria Feychting, Donghao Lu, Arvid Sjölander, Kamila Czene, Per Hall, Fang Fang. Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Breast Cancer: Evidence from a General Female Population and a Mammographic Screening Cohort in Sweden. Cancers 2023; 15(3) doi: 10.3390/cancers15030692
|
| 89 |
Mark E. Sherman, Robert A. Vierkant, Suneetha Kaggal, Tanya L. Hoskin, Marlene H. Frost, Lori Denison, Daniel W. Visscher, Jodi M. Carter, Stacey J. Winham, Matthew R. Jensen, Derek C. Radisky, Celine M. Vachon, Amy C. Degnim. Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy. Cancer Prevention Research 2020; 13(11) doi: 10.1158/1940-6207.CAPR-20-0178
|
| 90 |
Manoj Kumar, Sunil Kumar Dhatwalia, D. K. Dhawan. Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis. Tumor Biology 2016; 37(11) doi: 10.1007/s13277-016-5330-5
|
| 91 |
Y. X. Wang, Y. Z. Li, Z. Y. Zhang, J. Q. Wang, J. Cui, X. L. Qian. HPV16 E6 Promotes Breast Cancer Proliferation via Upregulation of COX-2 Expression. BioMed Research International 2017; 2017 doi: 10.1155/2017/2948467
|
| 92 |
Phuong H.L. Tran, Beom-Jin Lee, Thao T.D. Tran. Current Studies of Aspirin as an Anticancer Agent and Strategies to Strengthen its Therapeutic Application in Cancer. Current Pharmaceutical Design 2021; 27(18) doi: 10.2174/1381612826666201102101758
|
| 93 |
Dmytro Bilyi, Alona Hierdieva, Maksym Herhaulov, Viacheslav Vakulyk. Analysis of prognostic factors for feline mammary tumours (overview information). Scientific Horizons 2020; 23(10) doi: 10.48077/scihor.23(10).2020.99-109
|
| 94 |
Karla Esbona, Yanyao Yi, Sandeep Saha, Menggang Yu, Rachel R. Van Doorn, Matthew W. Conklin, Douglas S. Graham, Kari B. Wisinski, Suzanne M. Ponik, Kevin W. Eliceiri, Lee G. Wilke, Patricia J. Keely. The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma Patients. The American Journal of Pathology 2018; 188(3) doi: 10.1016/j.ajpath.2017.10.025
|
| 95 |
Reuben J. Hoffmann, AeSoon Bensen, Mark Dane, Jane Arterberry, Rebecca Smith, James Korkola, Pepper Schedin. S-nitrosylated COX-2 is a microenvironment-regulated breast cancer cell biomarker of mesenchymal phenotypes. Experimental Cell Research 2026; 456(1) doi: 10.1016/j.yexcr.2026.114888
|
| 96 |
Brian M. Kennedy, Randall E. Harris. Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer. Inflammopharmacology 2018; 26(4) doi: 10.1007/s10787-018-0489-6
|
| 97 |
Esraa Saadi, Sharon Tal, Liza Barki-Harrington. Substrate-inactivated cyclooxygenase-2 is disposed of by exosomes through the ER–Golgi pathway. Biochemical Journal 2018; 475(19) doi: 10.1042/BCJ20180530
|
| 98 |
José AG Agúndez, Miguel Blanca, José A Cornejo-García, Elena García-Martín. Pharmacogenomics of Cyclooxygenases. Pharmacogenomics 2015; 16(5) doi: 10.2217/pgs.15.6
|
| 99 |
Lisa Y. Pang, Emma A. Hurst, David J. Argyle, Zhi Sheng. Cyclooxygenase‐2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/2048731
|
| 100 |
D. Al Hussein, N. S. Stepanov, A. V. Nemtarev, A. A. Mostyakova, O. A. Timofeeva. Changes in the Phytochemical Composition of Humulus lupulus L. under the Influence of Bioregulators. Russian Journal of Plant Physiology 2025; 72(6) doi: 10.1134/S1021443725605087
|
| 101 |
Kristen M. C. Malecki. Epigenetics and differential effects of aspirin on breast cancer survival: Opportunities for understanding human susceptibility and risk. Cancer 2019; 125(21) doi: 10.1002/cncr.32365
|
| 102 |
D. V. Spector, A. A. Bubley, E. K. Beloglazkina, O. O. Krasnovskaya. Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action. Russian Chemical Reviews 2023; 92(10) doi: 10.59761/RCR5096
|
| 103 |
Dalal Al Hussein, Esraa Almugrabi, Antonina Mostyakova, Olga Timofeeva, D.V. Rudoy, A.V. Olshevskaya, E.N. Ponomareva, M.Yu. Odabashyan. Phytochemical composition of Humulus Lupulus L. in ontogeny under different treatments. E3S Web of Conferences 2023; 381 doi: 10.1051/e3sconf/202338101022
|
| 104 |
L. Bocquet, S. Sahpaz, J. L. Hilbert, C. Rambaud, C. Rivière. Humulus lupulus L., a very popular beer ingredient and medicinal plant: overview of its phytochemistry, its bioactivity, and its biotechnology. Phytochemistry Reviews 2018; 17(5) doi: 10.1007/s11101-018-9584-y
|
| 105 |
Pratistha Singh, Vinay Kumar Singh, Malkhey Verma. Molecular docking and dynamics simulation analyses of ibuprofen derivatives as potential anti-cancer agents targeting COX-2. In Silico Research in Biomedicine 2025; 1 doi: 10.1016/j.insi.2025.100100
|
| 106 |
Zulfa Zuhrufa, Tatang Shabur Julianto. Molecular Interaction Analysis of COX-2 Against Aryl Amino Alcohol Derivatives from Isoeugenol as Anti Breast Cancer using Molecular Docking. Bulletin of Chemical Reaction Engineering & Catalysis 2021; 16(3) doi: 10.9767/bcrec.16.3.10324.581-587
|
| 107 |
Madhuri Saindane, Harikrishna Reddy Rallabandi, Kyoung Sik Park, Alexander Heil, Sang Eun Nam, Young Bum Yoo, Jung-Hyun Yang, Ik Jin Yun. Prognostic Significance of Prostaglandin-Endoperoxide Synthase-2 Expressions in Human Breast Carcinoma: A Multiomic Approach. Cancer Informatics 2020; 19 doi: 10.1177/1176935120969696
|
| 108 |
Khalid M. Attalah, Ashraf N. Abdalla, Akhmed Aslam, Muhammad Ahmed, Mohammed A.S. Abourehab, Naser A. ElSawy, Ahmed M. Gouda. Ethyl benzoate bearing pyrrolizine/indolizine moieties: Design, synthesis and biological evaluation of anti-inflammatory and cytotoxic activities. Bioorganic Chemistry 2020; 94 doi: 10.1016/j.bioorg.2019.103371
|
| 109 |
Weiying Li, Wentao Yue, Hui Wang, Baitang Lai, Xuehui Yang, Chunyan Zhang, Yue Wang, Meng Gu. Cyclooxygenase-2 is associated with malignant phenotypes in human lung cancer. Oncology Letters 2016; 12(5) doi: 10.3892/ol.2016.5207
|
| 110 |
Miguel A. Ortega, Oscar Fraile-Martinez, Cielo García-Montero, Sandra Borja-Vergel, Diego Torres-Carranza, Leonel Pekarek, Coral Bravo Arribas, Juan A. De León-Luis, Cristina Sánchez-Rojo, Miguel Angel Alvarez-Mon, Natalio García-Honduvilla, Julia Buján, Santiago Coca, Melchor Alvarez-Mon, Miguel A. Saez, Luis G. Guijarro. Patients with Invasive Lobular Carcinoma Show a Significant Increase in IRS-4 Expression Compared to Infiltrative Ductal Carcinoma—A Histopathological Study. Medicina 2022; 58(6) doi: 10.3390/medicina58060722
|
| 111 |
Zuojie Li, Qingpeng Wang, Linming Li, Yan Chen, Jichun Cui, Min Liu, Ning Zhang, Zhifang Liu, Jun Han, Zhengping Wang. Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response. Journal of Medicinal Chemistry 2021; 64(24) doi: 10.1021/acs.jmedchem.1c01236
|
| 112 |
Yaqin Zhou, Ying Zhu. Important Role of the IL-32 Inflammatory Network in the Host Response against Viral Infection. Viruses 2015; 7(6) doi: 10.3390/v7062762
|
| 113 |
Chia-Chien Hsieh, Chi-Hao Wu, Shih-Han Peng, Chia-Hsin Chang. Seed-derived peptide lunasin suppressed breast cancer cell growth by regulating inflammatory mediators, aromatase, and estrogen receptors. Food & Nutrition Research 2023; 67 doi: 10.29219/fnr.v67.8991
|
| 114 |
Turan Emre Kuzu, Kübra Öztürk, Cem A. Gürgan, Arzu Yay, Özge Göktepe, Alpdoğan Kantarcı. Anti‐inflammatory and pro‐regenerative effects of a monoterpene glycoside on experimental periodontitis in a rat model of diabetes. Journal of Periodontal Research 2023; 58(5) doi: 10.1111/jre.13151
|
| 115 |
Helena Costa, Joel Touma, Belghis Davoudi, Melinda Benard, Torill Sauer, Jürgen Geisler, Katja Vetvik, Afsar Rahbar, Cecilia Söderberg-Naucler. Human cytomegalovirus infection is correlated with enhanced cyclooxygenase-2 and 5-lipoxygenase protein expression in breast cancer. Journal of Cancer Research and Clinical Oncology 2019; 145(8) doi: 10.1007/s00432-019-02946-8
|
| 116 |
Meitong Liu, Chenchen Xu, Bo Dong. The mechanisms and therapeutic advances of interactions between breast cancer and cardiovascular diseases. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1767098
|
| 117 |
Wenxia Liu, Yating Liu, Haiyan Fan, Min Liu, Jun Han, Yunfei An, Yue Dong, Bin Sun. Design, Synthesis, and Biological Evaluation of Dual-Target COX-2/CYP51 Inhibitors for the Treatment of Fungal Infectious Diseases. Journal of Medicinal Chemistry 2022; 65(18) doi: 10.1021/acs.jmedchem.2c00878
|
| 118 |
Eren Canbolat, Funda Pınar Cakıroglu. The importance of AMPK in obesity and chronic diseases and the relationship of AMPK with nutrition: a literature review. Critical Reviews in Food Science and Nutrition 2023; 63(4) doi: 10.1080/10408398.2022.2087595
|
| 119 |
Jennifer M. Mongiovi, Chi-Chen Hong, Gary R. Zirpoli, Thaer Khoury, Angela R. Omilian, Bo Qin, Elisa V. Bandera, Song Yao, Christine B. Ambrosone, Zhihong Gong. Genetic Variants in COX2 and ALOX Genes and Breast Cancer Risk in White and Black Women. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.679998
|
| 120 |
Vanessa Silva Pereira, Beatriz da Costa Aguiar Alves, Jaques Waisberg, Fernando Fonseca, Flavia Gehrke. Detection of COX-2 in liquid biopsy of patients with prostate cancer. Journal of Clinical Pathology 2023; 76(3) doi: 10.1136/jclinpath-2021-207755
|
| 121 |
Jing Wang, Fan Zhou, Hezhen Wang, Lei Zhang. Synthesis and cytotoxic activity of novel dihydroartemisinin-nonsteroidal anti-inflammatory drug conjugates. Natural Product Research 2026; doi: 10.1080/14786419.2026.2641231
|
| 122 |
Iuliia Filipenko, Stephanie Schwalm, Luca Reali, Josef Pfeilschifter, Doriano Fabbro, Andrea Huwiler, Uwe Zangemeister-Wittke. Upregulation of the S1P3 receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE2 and EP2/EP4 activation. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2016; 1861(11) doi: 10.1016/j.bbalip.2016.09.005
|
| 123 |
Hyo‐Min Park, Jae‐Young Park, Na‐Yeon Kim, Jinju Kim, Thu‐Huyen Pham, Jin Tae Hong, Do‐Young Yoon. Modulatory effects of point‐mutated IL‐32θ (A94V) on tumor progression in triple‐negative breast cancer cells. BioFactors 2024; 50(2) doi: 10.1002/biof.2005
|
| 124 |
Valentina Aristarco, Davide Serrano, Sara Gandini, Harriet Johansson, Debora Macis, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Irene Feroce, Giancarlo Pruneri, Gianmatteo Pagani, Antonio Toesca, Pietro Caldarella, Andrea DeCensi, Bernardo Bonanni. A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients. Cancer Prevention Research 2016; 9(5) doi: 10.1158/1940-6207.CAPR-15-0311
|
| 125 |
Yusuke Kanda, Mitsuhiko Osaki, Futoshi Okada. Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction. International Journal of Molecular Sciences 2017; 18(4) doi: 10.3390/ijms18040867
|
| 126 |
Ankita Sahu, Khalid Raza, Dibyabhaba Pradhan, Arun Kumar Jain, Saurabh Verma. Cyclooxygenase‐2 as a therapeutic target against human breast cancer: A comprehensive review. WIREs Mechanisms of Disease 2023; 15(3) doi: 10.1002/wsbm.1596
|
| 127 |
Abhijit Debnath, Rupa Mazumder. Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive Review. Current Cancer Drug Targets 2025; 25(6) doi: 10.2174/0115680096289260240311062343
|
| 128 |
Rosamaria Lappano, Marianna Talia, Francesca Cirillo, Damiano Cosimo Rigiracciolo, Domenica Scordamaglia, Rita Guzzi, Anna Maria Miglietta, Ernestina Marianna De Francesco, Antonino Belfiore, Andrew H. Sims, Marcello Maggiolini. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs). Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01667-y
|
| 129 |
Seon‐Mi Yu, Yohan Han, Song Ja Kim. Simvastatin abolishes nitric oxide‐ and reactive oxygen species‐induced cyclooxygenase‐2 expression by blocking the nuclear factor κB pathway in rabbit articular chondrocytes. Cell Biology International 2020; 44(10) doi: 10.1002/cbin.11424
|
| 130 |
Poonam Jawanjal, Sudha Salhan, Indrani Dhawan, Nirmalendu Das, Ruby Aggarwal, Richa Tripathi, Gayatri Rath. Augmented Activity of Cyclooxygenase‐2 in Tissue and Serum of Patients With Cervical Cancer. Journal of Clinical Laboratory Analysis 2016; 30(6) doi: 10.1002/jcla.22003
|
| 131 |
Ahmed M. Shawky, Mohammed A.S. Abourehab, Ashraf N. Abdalla, Ahmed M. Gouda. Optimization of pyrrolizine-based Schiff bases with 4-thiazolidinone motif: Design, synthesis and investigation of cytotoxicity and anti-inflammatory potency. European Journal of Medicinal Chemistry 2020; 185 doi: 10.1016/j.ejmech.2019.111780
|
| 132 |
Wanjun Li, Zhiwei Zhang, Baiyun Wang, Na Liang, Qier Zhou, Songkai Long. MicroRNA and cyclooxygenase-2 in breast cancer. Clinica Chimica Acta 2021; 522 doi: 10.1016/j.cca.2021.08.007
|
| 133 |
Wael A. A. Fadaly, Taha H. Zidan, Nesma M. Kahk, Fatma E. A. Mohamed, Marwa M. Abdelhakeem, Rehab G. Khalil, Mohamed T. M. Nemr. New pyrazolyl-thiazolidinone/thiazole derivatives as celecoxib/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis, molecular modelling and ADME studies. Journal of Enzyme Inhibition and Medicinal Chemistry 2023; 38(1) doi: 10.1080/14756366.2023.2281262
|
| 134 |
Yulia Liubomirski, Adit Ben-Baruch. Notch-Inflammation Networks in Regulation of Breast Cancer Progression. Cells 2020; 9(7) doi: 10.3390/cells9071576
|
| 135 |
. 2016; doi: 10.70675/21e9cc6bz15ffz4173zbb43zc39c25cc3830
|
| 136 |
Alex J. Kiraly, Eman Soliman, Audrey Jenkins, Rukiyah T. Van Dross. Apigenin inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice. Prostaglandins, Leukotrienes and Essential Fatty Acids 2016; 104 doi: 10.1016/j.plefa.2015.11.006
|
| 137 |
Patricia A. Thompson, Chuan Huang, Jie Yang, Betsy C. Wertheim, Denise Roe, Xiaoyue Zhang, Jie Ding, Pavani Chalasani, Christina Preece, Jessica Martinez, H.-H. Sherry Chow, Alison T. Stopeck. Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors. Clinical Cancer Research 2021; 27(20) doi: 10.1158/1078-0432.CCR-21-0732
|
| 138 |
Teresa P. Raposo, Hugo Arias-Pulido, Nabila Chaher, Steven N. Fiering, David J. Argyle, Justina Prada, Isabel Pires, Felisbina Luísa Queiroga. Comparative aspects of canine and human inflammatory breast cancer. Seminars in Oncology 2017; 44(4) doi: 10.1053/j.seminoncol.2017.10.012
|
| 139 |
Su Jin Yun, Bokyoung Lee, Kuniharu Komori, Mi Jin Lee, Byoung Gill Lee, Kyongmin Kim, Sun Park. Regulation of TIM-3 expression in a human T cell line by tumor-conditioned media and cyclic AMP-dependent signaling. Molecular Immunology 2019; 105 doi: 10.1016/j.molimm.2018.12.006
|
| 140 |
Shreena J. Desai, Ben Prickril, Avraham Rasooly. Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer. Nutrition and Cancer 2018; 70(3) doi: 10.1080/01635581.2018.1446091
|
| 141 |
Lin Deng, Ding-qing Feng, Bin Ling. Cyclooxygenase-2 promotes ovarian cancer cell migration and cisplatin resistance via regulating epithelial mesenchymal transition. Journal of Zhejiang University-SCIENCE B 2020; 21(4) doi: 10.1631/jzus.B1900445
|
| 142 |
. 2023; doi: 10.70675/0faa5c0fzeb6cz4888z8f6azae10aeb71722
|